These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36445914)

  • 1. Prevalence of comorbidities associated with sickle cell disease among non-elderly individuals with commercial insurance-A retrospective cohort study.
    Ramsey SD; Bender MA; Li L; Johnson KM; Jiao B; Devine B; Basu A
    PLoS One; 2022; 17(11):e0278137. PubMed ID: 36445914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance.
    Johnson KM; Jiao B; Ramsey SD; Bender MA; Devine B; Basu A
    Blood Adv; 2023 Feb; 7(3):365-374. PubMed ID: 35575558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and disease burden of sickle cell disease in France: A descriptive study based on a French nationwide claim database.
    Leleu H; Arlet JB; Habibi A; Etienne-Julan M; Khellaf M; Adjibi Y; Pirenne F; Pitel M; Granghaud A; Sinniah C; De Montalembert M; Galacteros F
    PLoS One; 2021; 16(7):e0253986. PubMed ID: 34242255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, Mortality, and Access to Care for Chronic Kidney Disease in Medicaid-Enrolled Adults With Sickle Cell Disease in California: Retrospective Cohort Study.
    Valle J; Lebensburger JD; Garimella PS; Gopal S
    JMIR Public Health Surveill; 2024 Jul; 10():e57290. PubMed ID: 39008353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of treatment patterns, healthcare resource utilization and cost of illness for sickle cell disease in Ghana: a private medical insurance claims database study.
    Marfo K; Dei-Adomakoh Y; Segbefia C; Dwomoh D; Edgal A; Ampah N; Ramachandrachar BC; Subramanyam K; Natarajan A; Egbujo O; Ataga KI
    BMC Health Serv Res; 2023 Sep; 23(1):1018. PubMed ID: 37735428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Economic Burden of End-Organ Damage Among Medicaid Patients with Sickle Cell Disease in the United States: A Population-Based Longitudinal Claims Study.
    Campbell A; Cong Z; Agodoa I; Song X; Martinez DJ; Black D; Lew CR; Varker H; Chan C; Lanzkron S
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1121-1129. PubMed ID: 32597290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardization of coding definitions for sickle cell disease complications: A systematic literature review.
    Ericksen PN; Dabbous F; Ghosh R; Shah S; Sun X; Meier ER; Colavecchia C
    Pharmacoepidemiol Drug Saf; 2024 Sep; 33(9):e5769. PubMed ID: 39205482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of hypertension and abnormal kidney function in children with sickle cell disease -a cross sectional review.
    Bodas P; Huang A; O'Riordan MA; Sedor JR; Dell KM
    BMC Nephrol; 2013 Oct; 14():237. PubMed ID: 24168027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transition to adult care in sickle cell disease: A longitudinal study of clinical characteristics and disease severity.
    Kayle M; Docherty SL; Sloane R; Tanabe P; Maslow G; Pan W; Shah N
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27463. PubMed ID: 30251318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, treatment, and outcomes of renal conditions in pediatric sickle cell disease.
    Stallworth JR; Tripathi A; Jerrell JM
    South Med J; 2011 Nov; 104(11):752-6. PubMed ID: 22024785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between clinical outcomes and metformin use in adults with sickle cell disease and diabetes mellitus.
    Badawy SM; Payne AB
    Blood Adv; 2019 Nov; 3(21):3297-3306. PubMed ID: 31698459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmonary complications of sickle cell disease in children].
    Pincez T; Calamy L; Germont Z; Lemoine A; Lopes AA; Massiot A; Tencer J; Thivent C; Hadchouel A
    Arch Pediatr; 2016 Oct; 23(10):1094-1106. PubMed ID: 27642150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative blood transfusions for sickle cell disease.
    Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of the long-term economic burden of severe sickle cell disease: a 5-year longitudinal analysis.
    Gallagher ME; Chawla A; Brady BL; Badawy SM
    J Med Econ; 2022; 25(1):1140-1148. PubMed ID: 36222016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidities in aging patients with sickle cell disease.
    Ballas SK
    Clin Hemorheol Microcirc; 2018; 68(2-3):129-145. PubMed ID: 29614628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of opioid use in sickle cell disease.
    Han J; Zhou J; Saraf SL; Gordeuk VR; Calip GS
    Pharmacoepidemiol Drug Saf; 2018 May; 27(5):479-486. PubMed ID: 28815799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States.
    Udeze C; Evans KA; Yang Y; Lillehaugen T; Manjelievskaia J; Mujumdar U; Li N; Andemariam B
    Adv Ther; 2023 Aug; 40(8):3543-3558. PubMed ID: 37332020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six-year population-based cohort analysis.
    Zhou J; Han J; Nutescu EA; Galanter WL; Walton SM; Gordeuk VR; Saraf SL; Calip GS
    Br J Haematol; 2019 Apr; 185(1):116-127. PubMed ID: 30714090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and cost of sickle cell disease in France: real-world analysis using data from the Echantillon Généraliste des Bénéficiaires.
    Beillat M; Durand-Zaleski I; Pirenne F; Bénard S; Chillotti L; Galacteros F
    Front Public Health; 2023; 11():1215605. PubMed ID: 37808997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of venous thromboembolism and its associations in a large racially homogenous population of sickle cell disease patients.
    Okoye HC; Ezekekwu C; Nwagha TU; Korubo K; Omunakwe HE; Nnachi OC; Madu AJ; Nwogoh B; Efobi CC; Muoghalu EA; Nonyelu C; Okoye AE; Obodo OI; Ugwu CS; Egolum MC; Nnachi OA; Okpala I
    Eur J Haematol; 2022 Oct; 109(4):321-326. PubMed ID: 35687045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.